CM93

· Crimson Biopharm Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CM93, covering 2024-08-21 to 2024-08-21. Get the full timeline:

Most recent: Clinical Trial Update: CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM) [Phase 1]

See pricing